Search clinical trials for: IV racemic methadone HCl

Total 103 results

Washington University School of Medicine

Completed

CYP2B6 Polymorphisms in Methadone Disposition

Healthy Volunteers

United States
Washington University School of Medicine

Completed

Methadone in Pediatric Anesthesiology II (MEPAII)

Pain

United States
University of Virginia

Completed

IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction

Scoliosis

United States
MetaPharm, Inc.

Completed

Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain
University of Utah
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Methadone Pharmacokinetics and Cardiac Effects in Newborns

Pain

United States
Amicus Therapeutics

Completed

A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers

Fabry Disease

Netherlands
Universitätsklinikum Hamburg-Eppendorf
Federal Ministry of Health, Germany; State of Northrhine-Westfalia; State of... and other collaborators

Completed

The German Project of Heroin Assisted Treatment of Opiate Dependent Patients

Opioid Dependence

Germany
Oslo University Hospital

Active, not recruiting

Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals (MePhaCard)

Drug Effect | Adverse Drug Effect | Heart Arrhythmia

Norway
Pontificia Universidad Catolica de Chile

Not yet recruiting

Methadone Pharmacokinetics in End-stage Renal Disease (MCKD)

Chronic Kidney Diseases | Pain, Acute | Post Operative Pain

Chile
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); Montefiore Medical Center; Fordham University

Completed

Neurocognitive Effects of Opiate Agonist Treatment (NEO)

HIV Infections | HIV | Opioid-Related Disorders

United States
Foundation for Innovative New Diagnostics, Switzerland

Completed

DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV

Hepatitis C Virus Infection

Ukraine
Lyndra Inc.
National Institute on Drug Abuse (NIDA)

Withdrawn

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Opioid Use Disorder, Moderate
Terran Biosciences Australia Pty Ltd

Recruiting

A Study of Idazoxan in Healthy Participants

Healthy

Australia
University of Pennsylvania
National Institute of Drug Abuse; Expertise France

Completed

Medication-assisted Treatment for Injecting Drug Users in Vietnam (OIT-HCMC)

HIV Infections | Opioid Use Disorder
Bahria University

Completed

Clinical Efficacy and Safety of Metformin Versus Apple Cider Vinegar (ACV) in Prediabetics (BUHSCK)

PreDiabetes

Pakistan
INSYS Therapeutics Inc

Completed

A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers

Healthy Volunteer

United States
Genentech, Inc.

Completed

A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)

Non-Small Cell Lung Cancer
Janssen-Cilag International NV
Alza Corporation, DE, USA

Completed

A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously (EuroTrans)

Pain | Pain, Postoperative | Analgesia, Patient-Controlled

France, United Kingdom, Germany, Spain, Switzerland, Sweden, Belgium, Austria, Denmark, Ireland
Duke University

Completed

Impact of Oral Antibiotic Treatment on C. Difficile (C-Diff)

Diarrhea | Enterocolitis | C. Difficile

United States
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...

Active, not recruiting

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D)

Type2 Diabetes | Renal Disease | Cardiovascular Events

United States
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)

Healthy

Egypt
Boehringer Ingelheim
Eli Lilly and Company

Completed

This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood

Healthy

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

Healthy

Germany
National Cancer Institute (NCI)

Completed

R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Sunovion

Completed

Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma

Asthma

United States
Genentech, Inc.

Completed

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

Non-Small Cell Lung Cancer

United States, Spain, Argentina, Israel, Hong Kong, Thailand, Australia, Belgium, Brazil, Bulgaria, Italy, Mexico, Philippines, Romania, Singapore, Taiwan, United Kingdom
Psych Atlanta

Completed

Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

Treatment Resistant Depression

United States
State University of New York - Downstate Medical...

Terminated

Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD

Diabetes Mellitus | End-Stage Renal Disease

United States
Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Completed

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Chronic Lymphocytic Leukemia (CLL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Chemotherapy-sensitive Lymphoma | Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma | Acute Biphenotypic Leukemia (ABL) | Acute Undifferentiated Leukemia (AUL)

United States
Merck Sharp & Dohme LLC

Terminated

A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)

Diabetes Mellitus, Type 2
Xiamen LP Pharmaceutical Co., Ltd

Recruiting

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

Chemotherapy-induced Nausea and Vomiting

United States
Postgraduate Institute of Medical Education and...

Completed

Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block

Respiratory Insufficiency

India
Celltrion

Completed

A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers

Healthy

Korea, Republic of
Galenicum Health

Completed

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

Type 2 Diabetes | Bioequivalence

Canada
Galenicum Health

Completed

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers

Diabetes Mellitus, Type 2 | Bioequivalence

Canada
Shire

Completed

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

United States, Canada
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
KineMed

Completed

The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Celltrion

Completed

A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers

Healthy

Korea, Republic of
AstraZeneca
Bristol-Myers Squibb

Completed

Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin

Type 2 Diabetes

China
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
Oslo University Hospital

Completed

Saxagliptin and Atherosclerosis (SAXATH)

Coronary Artery Disease | Diabetes Mellitus Type 2

Norway
University of Erlangen-Nürnberg Medical School

Completed

Effects of Saxagliptin on Endothelial Function (ESENDI)

Diabetes Mellitus Type 2

Germany
Shanghai Zhongshan Hospital
Chinese Medical Association

Completed

Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

China
Beijing Chao Yang Hospital

Unknown

Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes

Obesity | Type 2 Diabetes
AstraZeneca
Bristol-Myers Squibb

Completed

An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes (SCORE)

Type 2 Diabetes

United States, Peru, Mexico, Colombia, Costa Rica
Merck Sharp & Dohme LLC

Completed

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

Type 2 Diabetes Mellitus (T2DM)
University of Thessaly

Completed

Dimenydrinate vs Ondansetron for PONV (DONV) (DONV)

PONV in Laparoscopic Cholocystectomies

Greece

3

Subscribe